Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Combiflex Lipid Peri - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Combiflex Lipid Peri

Approved

STANDARD

Combiflex Lipid Peri

JW Life Science Corporation🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 3a19348980e949e9
Company: JW Life Science Corporation
Type: Standard

Approval Details

Approval Id: 3a19348980e949e9
Drug Approval Philippines Name: Combiflex Lipid Peri
Product Name: Combiflex Lipid Peri
Registration Number: DR-XY43760
Brand Name: Combiflex Lipid Peri
Generic Name: Lipid Emulsion + Amino Acids + Electrolytes + Glucose
Dosage Form: Emulsion for IV Infusion
Dosage Strength: [see reverse]
Manufacturer: JW Life Science Corporation
Importer: JW HEALTHCARE PHILIPPINES CORPORATION
Issuance Date: 24 December 2021
Expiry Date: 20 February 2027
Pharmacologic Category: Parenteral Nutrition
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

3a19348980e949e9

Type

Standard

Back to Philippines FDA Approvals